| Dr Evelyn Valencerina Gopez, MD | |
|
50 N Medical Dr, Salt Lake City, UT 84132-0001 | |
| (801) 581-2507 | |
| Not Available |
| Full Name | Dr Evelyn Valencerina Gopez |
|---|---|
| Gender | Female |
| Speciality | Pathology - Cytopathology |
| Location | 50 N Medical Dr, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831289438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | 339897-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Evelyn Valencerina Gopez, MD Po Box 58294, Salt Lake City, UT 84158-0294 Ph: (801) 587-4330 | Dr Evelyn Valencerina Gopez, MD 50 N Medical Dr, Salt Lake City, UT 84132-0001 Ph: (801) 581-2507 |
News Archive
Baxter International Inc. announced today that it has entered into a definitive agreement to acquire all of the hemophilia-related assets of a privately-held biopharmaceutical company, Archemix, and entered into an exclusive license agreement for certain related intellectual property assets.
In a discovery that may lead to a new treatment for breast cancer that has spread to the bone, a Princeton University research team has unraveled a mystery about how these tumors take root.
Noninvasive tumour genotyping using cell-free plasma DNA analysis is feasible, say US researchers who believe the technique will aid patient diagnosis and monitoring.
The World Health Organization's recommendation of broad deployment of the first malaria vaccine among children in Sub-Saharan Africa has been widely celebrated, but scientists warn it could face hurdles in its acquisition and distribution by endemic countries.
A pre-procedure bleeding risk score can accurately identify high-risk, high-cost patients and may provide an opportunity to employ bleeding avoidance strategies to improve patient outcomes and reduce total costs related to percutaneous coronary intervention (PCI) procedures, according to a retrospective study being presented March 26 at the 61st annual American College of Cardiology (ACC) scientific session.
› Verified 6 days ago
Dr. Bryce J. Parkinson, DO, MBA Pathology Medicare: Not Enrolled in Medicare Practice Location: 15 N Medical Dr Ste 1100, Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Yahya Daneshbod, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 15 N Medical Dr Ste 1100, Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Robert E. Rogers, MD, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: Eccles Insititute Of Human Genetics: 15 N Medical Dr., Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Dr. Melissa Hankins Cessna, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 8th Avenue & C Street, Salt Lake City, UT 84143 Phone: 801-408-1784 Fax: 801-408-5196 | |
Kajsa Elizabeth Affolter, Pathology Medicare: Accepting Medicare Assignments Practice Location: University Of Utah Hospital, 50 North Medical Drive, Salt Lake City, UT 84132 Phone: 801-581-2507 | |
David R. Anderson, DO Pathology Medicare: Not Enrolled in Medicare Practice Location: Eccles Insititute Of Human Genetics: 15 N Medical Dr., Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Peter E. Jensen, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2507 |